Consumer Feels Like...
Health Care: Drugs
Dynavax Technologies Corporation (DVAX: NASDAQ)
$4.15 -0.09 | -2.12%
02/09/12 - 04:00 PM ET
979.63K / 1.59M
Vol / Avg. Vol:4.24 / 4.24
Open / Prev. Close:4.15 - 4.29
Today's Range:1.75 - 4.48
52 Wk Range:27.71%
Performance YTD:TheStreet Rating:
Portfolios with DVAX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks of Top-Performing...
- ContributorStocks At New 52-Week Highs...
- Contributor13 Biotech Stocks Bought an...
- Contributor10 Pharma Stocks Under $3
- Contributor4 Biotech Penny Stocks to Buy
- UserMy Portfolio
- UserStarters
- Contributor6 Penny Stocks for the Biot...
- UserMy Folly
Latest DVAX Headlines from TheStreet
- 8 Stocks Under $10 Moving Higher 02.02.12 | 02:02 pm
- 10 Stocks of Top-Performing Funds in 2012 01.20.12 | 05:01 am
- Biotech Calendar: Key Dates for October 10.03.11 | 08:10 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- Dynavax Stock Gaps Down On Today's Open (DVAX) 07.20.11 | 09:07 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
- 4 Biotech Penny Stocks to Buy: Navellier 04.13.11 | 11:04 am
- Dynavax, Frontier Financial: Early Volume Plays 04.27.10 | 07:04 am
- Dynavax, Santarus: Early Volume Plays 04.15.10 | 07:04 am
- Sirius XM, Conolog: Early Volume Plays 03.23.10 | 09:03 am
Press Releases for DVAX
Partner Headlines for DVAX
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV Phase 3 Trial - Benzinga 10.06.11 | 04:10 pm
- 7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses - Seeking Alpha 03.29.11 | 08:03 am
- Data from Dynavax for HBV Candidate - Analyst Blog - Zacks 12.27.10 | 01:12 pm
- Dynavax Announces $30 Million Common Stock Purchase (DVAX) - Benzinga 09.20.10 | 04:09 pm
- UPDATE 1-Dynavax posts Q2 loss, shares fall - Reuters 07.30.10 | 05:07 pm
- UPDATE 1-Dynavax's flu vaccine shows promise, shares rise - Reuters 04.26.10 | 05:04 pm
- Healthcare, Technology Converge: Recent Biotech Deals - SeekingAlpha.com 04.19.10 | 05:04 am
- UPDATE 1-Dynavax hep B vaccine shows promise in kidney disease - Reuters 04.14.10 | 05:04 pm
- UPDATE 1-Dynavax to raise $44 mln from public offering - Reuters 04.13.10 | 07:04 am
